A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases

Nalpas Bertrand; Ichai Philippe; Jamot Laure; Carbonell Nicolas; Rudler Marika; Mathurin Philippe; Durand Francois; Gerken Guido; Manns Michael; Trautwein Christian; Larrey Dominique; Radenne Sylvie; Duvoux Christophe; Leroy Vincent; Bernuau Jacques; Faivre Jamila; Moniaux Nicolas; Brechot Christian; Amouyal Gilles; Amouyal Paul; Samuel Didier

doi:10.1371/journal.pone.0150733

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases

作者：Nalpas Bertrand; Ichai Philippe; Jamot Laure; Carbonell Nicolas; Rudler Marika; Mathurin Philippe; Durand Francois; Gerken Guido; Manns Michael; Trautwein Christian; Larrey Dominique; Radenne Sylvie; Duvoux Christophe; Leroy Vincent; Bernuau Jacques; Faivre Jamila; Moniaux Nicolas; Brechot Christian; Amouyal Gilles; Amouyal Paul; Samuel Didier

来源：PLos One, 2016, 11(3): e0150733.

DOI：10.1371/journal.pone.0150733